On Monday, Kala Bio Inc (NASDAQ: KALA) was -10.22% drop from the session before settling in for the closing price of $0.68. A 52-week range for KALA has been $0.61 – $20.60.
A company in the Healthcare sector has jumped its sales by 40.66% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 56.16%. With a float of $8.70 million, this company’s outstanding shares have now reached $10.73 million.
Kala Bio Inc (KALA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Kala Bio Inc stocks. The insider ownership of Kala Bio Inc is 18.91%, while institutional ownership is 9.73%. The most recent insider transaction that took place on Oct 23 ’25, was worth 125,464. In this transaction Director of this company sold 154,894 shares at a rate of $0.81, taking the stock ownership to the 103,540 shares. Before that another transaction happened on Oct 22 ’25, when Company’s CHIEF FINANCIAL OFFICER sold 32,230 for $0.83, making the entire transaction worth $26,751. This insider now owns 29,873 shares in total.
Kala Bio Inc (KALA) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -1.23 earnings per share (EPS) during the time that was better than consensus figure (set at -2.47) by 1.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 65.97% during the next five years compared to 40.66% growth over the previous five years of trading.
Kala Bio Inc (NASDAQ: KALA) Trading Performance Indicators
You can see what Kala Bio Inc (KALA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.94, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Kala Bio Inc (KALA)
Let’s dig in a bit further. During the last 5-days, its volume was 2.23 million. That was better than the volume of 2.16 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 1.14%.
During the past 100 days, Kala Bio Inc’s (KALA) raw stochastic average was set at 0.03%, which indicates a significant decrease from 0.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2404 in the past 14 days, which was lower than the 0.6901 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9273, while its 200-day Moving Average is $5.3514. However, in the short run, Kala Bio Inc’s stock first resistance to watch stands at $0.6488. Second resistance stands at $0.6914. The third major resistance level sits at $0.7158. If the price goes on to break the first support level at $0.5818, it is likely to go to the next support level at $0.5574. The third support level lies at $0.5148 if the price breaches the second support level.
Kala Bio Inc (NASDAQ: KALA) Key Stats
There are 9,830K outstanding shares of the company, which has a market capitalization of 6.50 million. As of now, sales total 0 K while income totals -38,510 K. Its latest quarter income was 0 K while its last quarter net income were -7,560 K.
